Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADN for Pulmonary Hypertension After M-TEER
NCT07662655Phase 1Recruiting
- Sponsor
- Xiamen Cardiovascular Hospital
- Start
- Jun 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial in pulmonary hypertension (PH) (2 arms), sponsored by Xiamen Cardiovascular Hospital. Primary endpoint: Clinical worsening event at 12 months. Started Jun 2026; status: recruiting.
02
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07662655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07662655.